Modular Drug-Loaded Nanocapsules with Metal Dome Layers as a Platform for Obtaining Synergistic Therapeutic Biological Activities
Open Access
- 20 October 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 15 (43) , 50330-50343
Abstract
Multifunctional drug-loaded polymer-metal nanocapsules have attracted increasing attention in drug delivery due to their multifunctional potential endowed by drug activity and response to physicochemical stimuli. Current chemical synthesis methods of polymer/metal capsules require specific optimization of the different components to produce particles with precise properties, being particularly complex for Janus structures combining polymers and ferromagnetic and highly reactive metals. With the aim to generate tunable synergistic nanotherapeutic actuation with enhanced drug effects, here we demonstrate a versatile hybrid chemical/physical fabrication strategy to incorporate different functional metals with tailored magnetic, optical, or chemical properties on solid drug-loaded polymer nanoparticles. As archetypical examples, we present poly(lactic-co-glycolic acid) (PLGA) nanoparticles (diameters 100-150 nm) loaded with paclitaxel, indocyanine green, or erythromycin that are half-capped by either Fe, Au, or Cu layers, respectively, with application in three biomedical models. The Fe coating on paclitaxel-loaded nanocapsules permitted efficient magnetic enhancement of the cancer spheroid assembly, with 40% reduction of the cross-section area after 24 h, as well as a higher paclitaxel effect. In addition, the Fe-PLGA nanocapsules enabled external contactless manipulation of multicellular cancer spheroids with a speed of 150 μm/s. The Au-coated and indocyanine green-loaded nanocapsules demonstrated theranostic potential and enhanced anticancer activity in vitro and in vivo due to noninvasive fluorescence imaging with long penetration near-infrared (NIR) light and simultaneous photothermal-photodynamic actuation, showing a 3.5-fold reduction in the tumor volume growth with only 5 min of NIR illumination. Finally, the Cu-coated erythromycin-loaded nanocapsules exhibited enhanced antibacterial activity with a 2.5-fold reduction in the MIC50 concentration with respect to the free or encapsulated drug. Altogether, this technology can extend a nearly unlimited combination of metals, polymers, and drugs, thus enabling the integration of magnetic, optical, and electrochemical properties in drug-loaded nanoparticles to externally control and improve a wide range of biomedical applications.Keywords
Funding Information
- Ministry of Science, Innovation and Universities (MAT2016-77391-R, PCIN2016-093, PDC2022-133036-I00, PID2019-106229RB-I00, RTI2018-095495-J-I00, RYC2019-027449)
- Fundación Ramón Areces (CIVP19A5922)
- Generalitat de Catalunya (2017-SGR-292, 2021-SGR-0065)
- European Commission (0305260, 756762)
- European Commission
This publication has 70 references indexed in Scilit:
- Development of a stability-indicating high performance liquid chromatography method for assay of erythromycin ethylsuccinate in powder for oral suspension dosage formArabian Journal of Chemistry, 2014
- Janus magnetic cellular spheroids for vascular tissue engineeringBiomaterials, 2014
- Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applicationsCurrent Opinion in Biotechnology, 2013
- Near-IR-triggered photothermal/photodynamic dual-modality therapy system via chitosan hybrid nanospheresBiomaterials, 2013
- PLGA-based nanoparticles: An overview of biomedical applicationsJournal of Controlled Release, 2012
- Synthesizing and stabilizing copper nanoparticles by coating with a silica layer in aqueous solutionJournal of the Ceramic Society of Japan, 2012
- Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agentsInternational Journal of Nanomedicine, 2011
- Bioinspired Nanocorals with Decoupled Cellular Targeting and Sensing FunctionalitySmall, 2010
- Chondrogenic differentiation of human mesenchymal stem cell aggregates via controlled release of TGF‐β1 from incorporated polymer microspheresJournal of Biomedical Materials Research Part A, 2009
- Poly (Lactide-co-Glycolide) Nanoparticles Containing Coumarin-6 for Suppository Delivery: In Vitro Release Profile and In Vivo Tissue DistributionDrug Delivery, 2004